Possible regulation of telomerase activity by transcription and alternative splicing of telomerase reverse transcriptase in human melanoma

Journal of Investigative Dermatology

Volumn 116, Issue 6, 2001, Pages 867-873

  Villa, R ^a   Della Porta, C ^a   Folini, M ^a   Daidone, M G ^a   Zaffaroni, N ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

Alternatively spliced human telomerase reverse transcriptase variants; Telomerase subunits

Indexed keywords

RNA DIRECTED DNA POLYMERASE; TELOMERASE;

ARTICLE; ENZYME ACTIVITY; ENZYME REGULATION; HUMAN; HUMAN CELL; MELANOMA; PRIORITY JOURNAL; RNA SPLICING; SKIN CARCINOGENESIS;

EID: 0034989980     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1747.2001.01343.x     Document Type: Article

References (45)

1. Telomere length predicts replicative capacity of human fibroblasts
2. Structure and function of telomeres
3. Extension of life-span by introduction of telomerase into normal human cells
4. Evidence for an alternative mechanisn for maintaining telomere length in human tumors and tumor derived cell lines
5. The human telomerase catalytic subunit h TERT: Organization of the gene and characterization of the promoter
6. Cell kinetics: An independent prognostic variable in stage II melanoma of the skin
7. Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity
8. The RNA component of human telomerase
9. Inhibition of telomerase activity by a hammerhead ribozyme targeting the RNA component of telomerase in human melanoma cells
10. Increase in telomerase activity during progression of melanocytic naevi to malignant melanomas
11. Telomemse activity, cell proliferation, and cancer
12. Creation of human tumour cells with defined genetic elements
13. Telomerase activity in the regenerative basal layer of the epidermis in human skin and immortal and carcinoma-derived skin keratinocytes
14. Telomere loss: Mitotic clock or genetic time bomb?
15. A mammalian telomerase-asscciated protein
16. Human telomerase contains evolutionarily conserved catalytic and structural subunits
17. Telomerase expression in uveal melanoma
18. Functional requirement of p23 and hsp90 in telomerase complexes
19. Expression of human telomerase subunits and correlation with telomerase activity in urothelial cancer
20. hTERT is a criticai determinant of telomerase activity in renal cell carcinoma
21. Akt protein kinase enhances human telomerase activity through phosphorylation of telomerase reverse transcriptase subunit
22. Specific association of human telomerase activity with immortal cells and cancer
23. Human telomerase reverse transcriptase as a critical determinant of telomerase activity in normal and malignant endometrial tissues
24. Protein phosphatase 2A inhibits nuclear telomerase activity in human breast cancer cells
25. Telomerase is controlled by protein kinase C alpha in human breast cancer cells
26. hEst2 the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization
27. Telomerase catalytic subunit homologs from fission yeast and human
28. Telomerase activity in melanoma and non-melanoma skin cancer
29. Repression of an alternative mechanism for lengthening of telomeres in somatic cell hybrids
30. Expression profile of the putative catalytic subunit of the telomerase gene
31. Telomeres, telomerase, and immortality
32. Tankyrase, a poly(ADP-ribose) polymerase at human telomeres
33. Control of telomere length by the human telomeric protein TRF1
34. Telomerase components as a diagnostic tool in human oral lesions
35. Detection of telomerase activity in malignant and nonmalignant skin conditions
36. Evidence for UV-associated activation of telomerase in human skin cancer
37. Telomerase activity in human development is regulated by human telomerase reverse transcriptase (hTERT) transcription and by alternate splicing of hTERT transcripts
38. Regulation of telomerase by alternate splicing of human telomerase reverse transcriptase (hTERT) in normal and neoplastic ovary, endometrium and myometrium
39. Telomerase activity in benign and malignant breast lesions: A pilot prospective study on fine-needle aspirates
40. Origin of concatemeric T7 DNA
41. Reconstitution of human telomerase with the template RNA component hTR and the catalytic protein subunit hTRT
42. Genomic organization and promoter characterisation of the gene encoding the human telomerase reverse transcriptase (hTERT)
43. Correlation of the expression of human telomerase subunits with telomerase activity in normal skin and skin tumors
44. Direct activation of TENT transcription by c-MYC
45. Established melanoma cell lines from different metastatic nodules of a single patient. A useful model for cancer therapy